“...The costs of developing the types of new drugs that have been pursued by traditional pharmaceutical firms have been estimated in a number of studies. However,...”

“...Review existing studies and provide new results on the development, regulatory, and market aspects of new oncology drug development. We utilized data from the...”

“...The Tufts Center for the Study of Drug Development designed the recent study of the costs of new drug research and development to capture only the costs...”

“...The development of 'follow on' or 'me too' drugs - generally defined as a drug with a similar chemical structure or the same mechanism of action as a drug that...”

“...Recent studies have highlighted a reduction in projected financial returns associated with biopharmaceutical R&D, owing to decreased productivity, increases in...”

“...In a widely cited article, DiMasi, Hansen, and Grabowski (2003) estimate the average pre‐tax cost of bringing a new molecular entity to market. Their base case...”

“...This study examines what is generally regarded to be the most important measure of innovation in the pharmaceutical industry—the extent to which new drugs are...”

“...Studies indicate that the prevalence of multidrug-resistant infections, including hospital-acquired bacterial pneumonia and ventilator-associated bacterial...”

“...We examined the regulatory review histories of 298 approved new drugs and biologics with new drug applications (NDAs) or new biologic license applications...”